health kiosk for diagnostic device for breathing delivery system - - PowerPoint PPT Presentation

health kiosk for
SMART_READER_LITE
LIVE PREVIEW

health kiosk for diagnostic device for breathing delivery system - - PowerPoint PPT Presentation

Cancer screening R&D and cancer Air cylinder filling station and multipoint Wearable pathogen health kiosk for diagnostic device for breathing delivery system with pathogen neutralisation public use clinicians and researchers


slide-1
SLIDE 1

Cancer screening health kiosk for public use R&D and cancer diagnostic device for clinicians and researchers Wearable pathogen neutralisation Breathing device Air cylinder filling station and multipoint breathing delivery system with pathogen neutralising technology

slide-2
SLIDE 2

CORPORATE OVERVIEW

  • Products and technologies are focused on early cancer and pathologies screening* and breathing

air decontamination* for the medical market Privately owned

  • 100% Canadian company
  • A growing patent portfolio to protect IP worldwide

– DEVICES FOR TREATING AIR FOR INHALATION AND EXHALATION, GAMACHE, Yves and LAMONTAGNE, Andre. – WEARABLE DEVICES FOR TREATING AIR FOR INHALATION AND EXHALATION, GAMACHE, Yves and LAMONTAGNE, Andre. – ANALYTICAL METHOD FOR THE MEASUREMENT OF VOC IN EXHALED BREATH FOR EARLY CANCER DIAGNOSTIC, GAMACHE, Yves and LAMONTAGNE, Andre.

  • Exclusive technology license from ASDevices for OEM GC components: Sensor, Valves, Purifiers

and signal processing algorithm for the medical market

*patent pending

eTrace Medical Diagnostics

slide-3
SLIDE 3

CORPORATE OVERVIEW MANAGEMENT TEAM

André Lamontagne, ing

President

  • eMBA Harvard Business School
  • Electronics engineer
  • 20 years experience in the

analytical field

  • 4 patents

Yves Gamache

CEO/CTO

  • Serial entrepreneur
  • Renowned expert in the

analytical field

  • 130 patents

Dario Pietrantonio

Lawyer – Business Law & IP

  • Partner, Robic, LLP
  • Member of Robic management

committee

  • Best Lawyers Canada 2019,

2020 : Technology Law

Jean Fortier

CPA / CA

  • Partner, Deloitte
  • Business tax

Dr Alexandra Allard-Coutu

Medical / Clinical trials

  • Master of Surgery program at

McGill

  • Bachelor of Science in

Microbiology and Immunology at McGill University

  • Honors Immunology Research

Program

ADVISORY BOARD

slide-4
SLIDE 4

PRODUCTS TREE

Wearable breathing device Breathing devices with pathogen neutralisation Air cylinder filling station Multi-points breathing delivery system Room air purification Helium Recycling system for medical devices (MRI) Cancer screening and diagnostics devices Cancer screening Health Kiosk for public use R&D and cancer diagnostics device for clinician and researchers

slide-5
SLIDE 5

CANCER SCREENING AND DIAGNOSTIC DEVICES AeolCare technology – A life saving breath ™

CANCER SCREENING HEALTH KIOSK FOR PUBLIC USE R&D AND CANCER DIAGNOSTIC DEVICE FOR CLINICIAN AND RESEARCHERS

Health kiosk cancer screening R&D and Diagnostic device

slide-6
SLIDE 6

CANCER GLOBAL STATISTICS

  • 14 million new cancers, with over 8 million cancer

deaths, annually worldwide

  • Population models predict over 27.5 million new

diagnosis of cancer per year by 2040, with 16.3 million cancer-related deaths annually

  • Cancer care costs continue to climb yearly

– $124.5 billion USD in the United States – $7.5 billion in Canada – €86 billion in the European Union

  • The cost of cancer care can be staggering

– The average cost of for cancer care is estimated to be as much as $150 000 and treatments can cost up to $30 000 per month

slide-7
SLIDE 7

VOC AS BIOMARKER

  • Several innovations in cancer detection have been

developed in recent decades due to a growing need for early diagnosis and accurate screening tools

  • Volatile organic compound (VOC) analysis has

recently captured the interest of the scientific community

  • Endogenous VOCs are produced within the human

body as a result of metabolic biochemical pathways

  • Metabolic changes associated with the

pathophysiology have been shown to trigger shifts in exhaled VOCs

  • VOC profiles represent promising oncologic

biomarkers

slide-8
SLIDE 8

A 100% RELIABLE AND ACCURATE VOC ANALYSIS IN EXHALED BREATH TECHNOLOGY

  • The technology uses eTrace Medical unique analytical methodpatent pending to measure VOCs in Exhaled
  • Breath. The unique methods makes the analysis 100% accurate, 100% of the time.
  • ASDevices technologies are used by the gas chromatographic system to accurately measure VOCs

CANCER SCREENING AND DIAGNOSTIC DEVICES BASED ON ASDevices ON eTrace Medical TECHNOLOGIES

slide-9
SLIDE 9

CANCER SCREENING HEALTH KIOSK FOR PUBLIC USE

  • Early cancer screening Health Kiosk

– This screening device is intended as a “first layer test” to follow the health condition of users over time and detect pathologies at a very early stage – Public and volume deployment in service points like drug stores and club stores – Easy to use by anybody, no health professional required – Early disease detection aims at saving life and reducing healthcare cost – The profile of specific VOC biomarkers is monitored and used to provide health check recommendations

slide-10
SLIDE 10

HEALTH KIOSK ECOSYSTEM

  • Designed to be easy to use and easily accessible in service points such as drug stores or private

health check companies

  • A fully embedded ecosystem that allows patients to follow their health conditions and obtain

professional advices and services

slide-11
SLIDE 11

R&D AND CANCER DIAGNOSTICZ DEVICE FOR CLINICIANZ AND RESEARCHERS

  • DESIGNED TO EXPAND OUR BIOMARKER

KNOWLEDGE/DATABASE AND PROVIDE SPECIFIC CANCER DIAGNOSIC TOOLS

– Designed as a R&D device for VOCs in Exhaled breath research

  • Analytical configuration can be changed by researchers
  • Advanced data management
  • IIoT and Big Data analytics
  • Designed to expand our VOC Biomarker knowledge and

expand the scope of use of our technology – Can be configured as a specific cancer diagnostic tool for clinicians

  • Fully integrated analytical configuration
slide-12
SLIDE 12

WEARABLE AIR BREATHNING DEVICES WITH PATHOGEN NEUTRALISATION

DESIGNED FOR THE FRONT LINE KILLS COVID-19 & OTHER PATHOGENS

HEALTCARE WORKERS FIELD WORKERS MANUFACTURING LINE WORKERS

slide-13
SLIDE 13

WEARABLE AIR BREATHNING DEVICES WITH PATHOGEN NEUTRALISATION

  • A pathogen killer, not a pathogen trap like a N95 mask

– Filter both inhaled and exhaled air* – Inhaled air pathogens neutralisation using Thermal reactor and bacteria trap* – Exhaled air pathogens neutralisation using Embedded DBD Plasma and UV sterilisation*

  • No waste—Reusable and washable mask
  • Ergonomic

– Easy to breath, don’t waste energy breathing through an

  • bstructed dirty mask

– Positive air pressure supply from blower continuously provides air flow, even after hours of use.

  • Compatible with many types of mask

– Half-face and Full-face different mask compatible – Positive air pressure supply eliminates the risk of contamination from ambient air ingress into the mask. – Optional microphone and speaker for communication

FRONT LINE WEARABLE BREATHING DEVICE FOR HEALTHCARE WORKERS AGAINST COVID-19 & OTHER PATHOGENS

Full-face mask

slide-14
SLIDE 14

WEARABLE AIR BREATHNING DEVICES WITH PATHOGEN NEUTRALISATION

  • A simple pathogen neutralisation processpatent pending

– Our technology is not a trapping system like N95 masks. It has been designed to neutralise pathogens, kill them. An inactive pathogen is armless, a trapped one is still dangerous. – Pathogens in inhaled air are neutralised using our low power thermal reactor*. – Pathogens in exhaled air are neutralised using a Plasma DBD (Dielectric Barrier Discharge) zone.

slide-15
SLIDE 15

WEARABLE AIR BREATHNING DEVICES WITH PATHOGEN NEUTRALISATION

  • SUPER HEATING PROCESS

– Pathogens are very often contained in droplets that are expelled during a cough or sneeze – This superheating process vaporises droplets and consequently free pathogens, making them easier to neutralise.

  • INCREASING PATHOGEN RESIDENCE TIME IN REACTORS

– The pathogens are trapped inside a layer of porous material in the reactor – The air velocity is almost not impacted while the pathogens velocity rapidly decreases, increasing neutralisation efficiency

slide-16
SLIDE 16

HIGH AIR FLOW PATHOGEN NEUTRALISATION DEVICES

DESIGNED FOR MULTI-POINTS BREATHING SYSTEM, INCUBATORS AND ROOM AIR FILTERING

CLEAN ROOMS INDUSTRIAL AIR DELIVERY INCUBATORS

slide-17
SLIDE 17

HIGH AIR FLOW PATHOGEN NEUTRALISATION DEVICES

  • Not a pathogen trap, but a pathogen killer
  • Fail-safe process optimised high flowpatent pending

– Thermal, UV, DBD and O3 pathogen neutraliser – Pathogen outlet filter

  • Easy maintenance
  • Embedded alarm monitoring
  • Various size available
  • Multi-point delivery system

– Provide purified air to multiple masks – Provide purified air to multiple workers – Provide purified air to multiple patients – Provide purified air to an existing air delivery system – Provide purified air to a mechanical respirator

  • Cylinder fill-in station

Four-steps fail safe neutralisation process

slide-18
SLIDE 18

HIGH AIR FLOW PATHOGEN NEUTRALISATION DEVICES

Masks Incubator

Multi-points air breathing delivery system Pathogen free air cylinder filling station Pathogen neutralisation for room air purification

slide-19
SLIDE 19

HELIUM RECYCLING SYSTEM FOR MEDICAL DEVICES

DESIGNED FOR MEDICAL DEVICES SUCH AS MRI REDUCES HOSPITALS HELIUM ANNUAL BILL

slide-20
SLIDE 20

HELIUM RECYCLING SYSTEM FOR MEDICAL DEVICES

  • Helium is the lifeblood of MRI Devices
  • Helium price is continuously increasing and it

is not a renewable resource

  • Recycling helium is now requested by

hospitals which are seeing their helium bill increasing every year

  • Helium can be recycled based on a

proprietary process

  • A proprietary recycling process using

ASDevices technologies

– Re-purifying helium using ASDevices purification technology – Continuous quality control of helium using ASDevices Epd sensing technology Pump system Purification Quality control Storage tank Waste helium Recycled helium